Preprint2021
Randomized Phase III Trial of Intravenous And Intraperitoneal Paclitaxel With S-1 Versus Gemcitabine Plus Nab-Paclitaxel For Pancreatic Ductal Adenocarcinoma With Peritoneal Metastasis (SP Study)
- Published
- 30 July 2021
- Citations
- 0
- Type
- Preprint
- License
- cc by
These are bibliographic fields. A study card, with population, design, endpoints and result direction each tied to a quote, is not in the data yet.
Ask this document
Answers come only from this document’s own text, as highlighted quotes. If it doesn’t say, you are told so instead of given a guess. Only its metadata is loaded so far, so most questions will be declined.
Try